FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2909669915> ?p ?o ?g. }

• W2909669915 endingPage "260" @default.
• W2909669915 startingPage "249" @default.
• W2909669915 abstract "In contrast to randomized controlled trials (RCTs), changes in maintenance pharmacotherapy in clinical practice occur without a washout period. The Prospective cohort study for the real-life effectiveness evaluation of glycOpyrronium With indacatERol combination in the management of COPD in Canada (POWER) study evaluated the real-life effectiveness of indacaterol/glycopyrronium (IND/GLY) following a direct switch from a long-acting muscarinic antagonist (LAMA, tiotropium) or long-acting β2-agonist (LABA)/inhaled corticosteroid (ICS) maintenance treatment (salmeterol/fluticasone [SFC]).POWER was a single-cohort, prospective, multicenter, interventional study in which patients with moderate-to-severe COPD, who remained symptomatic on their current treatment of once-daily (od) tiotropium 18 µg or twice-daily (bid) SFC (any dose), were switched to treatment with open-label IND/GLY 110/50 µg od for 16 weeks. Effectiveness end points were change from baseline in trough FEV1, transition dyspnea index (TDI) total scores, and COPD assessment test (CAT) scores at 16 weeks.Trough FEV1 improved by 175 mL at Week 16 in patients who switched to IND/GLY. The change was 176 mL (95% CI: 135-217) when switched from tiotropium and 172 mL (95% CI: 85-258) when switched from SFC fixed-dose combination (FDC). At Week 16, significant improvements were observed in the mean TDI total scores (Δ=2.5) and CAT scores (Δ=-6.5) after the switch to IND/GLY treatment (both P<0.0001). Additionally, IND/GLY was well tolerated in patients with moderate-to-severe COPD, and no safety signal was observed.In clinical practice settings, a direct switch from previous treatment with either tiotropium or SFC to IND/GLY was safe and provided superior clinically significant improvements in lung function and patient-related outcomes in patients with moderate-to-severe COPD.NCT02202616." @default.
• W2909669915 created "2019-01-25" @default.
• W2909669915 creator A5004732852 @default.
• W2909669915 creator A5009576680 @default.
• W2909669915 creator A5031078442 @default.
• W2909669915 creator A5036017418 @default.
• W2909669915 creator A5040011739 @default.
• W2909669915 creator A5043373594 @default.
• W2909669915 creator A5058683482 @default.
• W2909669915 creator A5073165570 @default.
• W2909669915 date "2019-01-01" @default.
• W2909669915 modified "2023-10-11" @default.
• W2909669915 title "<p>Real-life effectiveness of indacaterol&ndash;glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER study</p>" @default.
• W2909669915 cites W1637753636 @default.
• W2909669915 cites W1909024616 @default.
• W2909669915 cites W197469462 @default.
• W2909669915 cites W1987881697 @default.
• W2909669915 cites W2000172698 @default.
• W2909669915 cites W2093577653 @default.
• W2909669915 cites W2101849970 @default.
• W2909669915 cites W2101978351 @default.
• W2909669915 cites W2108145404 @default.
• W2909669915 cites W2116505643 @default.
• W2909669915 cites W2120356269 @default.
• W2909669915 cites W2122286642 @default.
• W2909669915 cites W2123850585 @default.
• W2909669915 cites W2127951128 @default.
• W2909669915 cites W2133986277 @default.
• W2909669915 cites W2135482534 @default.
• W2909669915 cites W2141881375 @default.
• W2909669915 cites W2142449488 @default.
• W2909669915 cites W2155631558 @default.
• W2909669915 cites W2169045014 @default.
• W2909669915 cites W2209473605 @default.
• W2909669915 cites W2324038222 @default.
• W2909669915 cites W2330533577 @default.
• W2909669915 cites W2344148139 @default.
• W2909669915 cites W2365138737 @default.
• W2909669915 cites W2513086234 @default.
• W2909669915 cites W2520579059 @default.
• W2909669915 cites W2594397173 @default.
• W2909669915 cites W2604577460 @default.
• W2909669915 cites W2738246554 @default.
• W2909669915 cites W2744121074 @default.
• W2909669915 cites W2766688689 @default.
• W2909669915 cites W2785993208 @default.
• W2909669915 cites W2785999277 @default.
• W2909669915 cites W2794699839 @default.
• W2909669915 cites W2801664602 @default.
• W2909669915 cites W2802221596 @default.
• W2909669915 cites W2804974357 @default.
• W2909669915 cites W2888549501 @default.
• W2909669915 cites W2891482814 @default.
• W2909669915 cites W4210297421 @default.
• W2909669915 cites W4211263216 @default.
• W2909669915 doi "https://doi.org/10.2147/copd.s185485" @default.
• W2909669915 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6343749" @default.
• W2909669915 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30718952" @default.
• W2909669915 hasPublicationYear "2019" @default.
• W2909669915 type Work @default.
• W2909669915 sameAs 2909669915 @default.
• W2909669915 citedByCount "10" @default.
• W2909669915 countsByYear W29096699152019 @default.
• W2909669915 countsByYear W29096699152020 @default.
• W2909669915 countsByYear W29096699152021 @default.
• W2909669915 countsByYear W29096699152022 @default.
• W2909669915 crossrefType "journal-article" @default.
• W2909669915 hasAuthorship W2909669915A5004732852 @default.
• W2909669915 hasAuthorship W2909669915A5009576680 @default.
• W2909669915 hasAuthorship W2909669915A5031078442 @default.
• W2909669915 hasAuthorship W2909669915A5036017418 @default.
• W2909669915 hasAuthorship W2909669915A5040011739 @default.
• W2909669915 hasAuthorship W2909669915A5043373594 @default.
• W2909669915 hasAuthorship W2909669915A5058683482 @default.
• W2909669915 hasAuthorship W2909669915A5073165570 @default.
• W2909669915 hasBestOaLocation W29096699151 @default.
• W2909669915 hasConcept C126322002 @default.
• W2909669915 hasConcept C170493617 @default.
• W2909669915 hasConcept C188816634 @default.
• W2909669915 hasConcept C2776042228 @default.
• W2909669915 hasConcept C2776694085 @default.
• W2909669915 hasConcept C2776719499 @default.
• W2909669915 hasConcept C2776723954 @default.
• W2909669915 hasConcept C2776780178 @default.
• W2909669915 hasConcept C2776804153 @default.
• W2909669915 hasConcept C2776885963 @default.
• W2909669915 hasConcept C2776999253 @default.
• W2909669915 hasConcept C2778283404 @default.
• W2909669915 hasConcept C2778884479 @default.
• W2909669915 hasConcept C2779028295 @default.
• W2909669915 hasConcept C2780911369 @default.
• W2909669915 hasConcept C2781018748 @default.
• W2909669915 hasConcept C42219234 @default.
• W2909669915 hasConcept C71924100 @default.
• W2909669915 hasConceptScore W2909669915C126322002 @default.
• W2909669915 hasConceptScore W2909669915C170493617 @default.
• W2909669915 hasConceptScore W2909669915C188816634 @default.
• W2909669915 hasConceptScore W2909669915C2776042228 @default.

• next